John Ornell Biography and Net Worth

Director of Bruker

Mr. Ornell is retired from Waters Corporation (“Waters”), where he served as Vice President, Finance and Administration and Chief Financial Officer from 2001 to 2013. During his time at Waters, he was also responsible for information technology, investor relations and the TA Instruments Division. Joining Waters in 1994, Mr. Ornell served in a variety of operational and financial leadership roles before assuming the position of Waters’ Chief Financial Officer. During 2014, Mr. Ornell continued to serve Waters on a part-time, transitional basis. Prior to joining Waters, Mr. Ornell progressed through a series of roles of increasing responsibility at a number of multinational corporations, primarily in operational finance functions. Mr. Ornell holds a Bachelor of Science degree in Business Administration and a Bachelor of Arts degree in Economics from the University of New Hampshire, as well as a Master of Business Administration degree from Southern New Hampshire University. He is a Certified Management Accountant and a Certified Public Accountant. Mr. Ornell brings to the Board a depth of knowledge in the life sciences and analytical instruments industry, as well as a global perspective with significant experience managing the operational, strategic and financial matters of life sciences companies. Mr. Ornell serves as Chair of our Audit Committee.

What is John A. Ornell's net worth?: The estimated net worth of John A. Ornell is at least $1.59 million as of November 6th, 2025. Ornell owns 35,212 shares of Bruker stock worth more than $1,589,118 as of December 12th. This net worth estimate does not reflect any other assets that Ornell may own. Learn More about John A. Ornell's net worth.
How do I contact John A. Ornell?: The corporate mailing address for Ornell and other Bruker executives is 40 Manning Road, Billerica MA, 01821. Bruker can also be reached via phone at (978) 663-3660 and via email at [email protected]. Learn More on John A. Ornell's contact information.
Has John A. Ornell been buying or selling shares of Bruker?: During the past quarter, John A. Ornell has sold $243,087.00 in shares of Bruker stock. Most recently, John A. Ornell sold 6,233 shares of the business's stock in a transaction on Thursday, November 6th. The shares were sold at an average price of $39.00, for a transaction totalling $243,087.00. Following the completion of the sale, the director now directly owns 35,212 shares of the company's stock, valued at $1,373,268. Learn More on John A. Ornell's trading history.
Who are Bruker's active insiders?: Bruker's insider roster includes Thomas Bures (CAO), Cynthia Friend (Director), Gerald Herman (CFO), Marc Kastner (Director), Frank Laukien (CEO), Mark Munch (VP), John Ornell (Director), Richard Packer (Director), and Hermann Requardt (Director). Learn More on Bruker's active insiders.
Are insiders buying or selling shares of Bruker?: In the last year, Bruker insiders bought shares 2 times. They purchased a total of 3,108 shares worth more than $123,742.88. In the last year, insiders at the medical research company sold shares 2 times. They sold a total of 9,768 shares worth more than $357,090.75. The most recent insider tranaction occured on November, 6th when Director John A Ornell sold 6,233 shares worth more than $243,087.00. Insiders at Bruker own 27.3% of the company. Learn More about insider trades at Bruker.
Information on this page was last updated on 11/6/2025.

John A. Ornell Insider Trading History at Bruker

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/6/2025	Sell	6,233	$39.00	$243,087.00	35,212

John A. Ornell Buying and Selling Activity at Bruker

Bruker Company Overview

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Today's Range

Now: $45.13

$45.00

$47.90

50 Day Range

MA: $41.68

$34.56

$49.33

2 Week Range

Now: $45.13

$28.53

$64.64

Volume

1,712,336 shs

Average Volume

2,288,846 shs

Market Capitalization

$6.86 billion

P/E Ratio

N/A

Dividend Yield

0.43%

Beta

1.17